Sulfonyl compounds as inhibitors of 11-beta-hydroxysteroid dehydro- genase-1

Details for Australian Patent Application No. 2005271527 (hide)

Owner Merck & Co., Inc.

Inventors Maletic, Milana; Waddell, Sherman T.; Gu, Xin; Leeman, Aaron H.; Santorelli, Gina M.; Balkovec, James M.

Agent Spruson & Ferguson

Pub. Number AU-B-2005271527

PCT Pub. Number WO2006/017542

Priority 60/599,361 06.08.04 US

Filing date 3 August 2005

Wipo publication date 16 February 2006

Acceptance publication date 27 August 2009

International Classifications

C07D 209/02 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/403 (2006.01) - condensed with carbocyclic rings, e.g. carbazole

A61K 31/46 (2006.01) - 8-Azabicyclo [3.2.1] octane

C07D 221/22 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups

Event Publications

22 February 2007 PCT application entered the National Phase

  PCT publication WO2006/017542 Priority application(s): WO2006/017542

27 August 2009 Application Accepted

  Published as AU-B-2005271527

24 December 2009 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend the Patentee from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005271528-Lenslet array for beam homogenization

2005271526-Antidiabetic oral insulin-biguanide combination